ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 59 filers reported holding ADAGIO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,703,596 | +31.3% | 8,060,939 | -18.9% | 0.00% | 0.0% |
| Q2 2023 | $10,436,318 | -68.8% | 9,939,351 | -64.4% | 0.00% | -50.0% |
| Q1 2023 | $33,477,444 | +58.2% | 27,897,870 | +97.7% | 0.00% | 0.0% |
| Q4 2022 | $21,166,473 | -55.2% | 14,110,982 | -6.5% | 0.00% | -60.0% |
| Q3 2022 | $47,240,000 | -5.5% | 15,092,406 | -0.9% | 0.01% | 0.0% |
| Q2 2022 | $49,965,000 | -28.1% | 15,233,411 | +0.0% | 0.01% | -16.7% |
| Q1 2022 | $69,464,000 | -36.6% | 15,233,378 | -2.3% | 0.01% | -25.0% |
| Q4 2021 | $109,584,000 | -83.5% | 15,592,582 | -6.6% | 0.01% | -84.9% |
| Q3 2021 | $662,801,000 | – | 16,687,749 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 6,398,250 | $20,986,000 | 23.53% |
| Foresite Capital Management V, LLC | 1,431,826 | $4,696,000 | 3.28% |
| Alphabet Inc. | 5,680,785 | $18,633,000 | 1.01% |
| 683 Capital Management, LLC | 3,603,637 | $11,820,000 | 0.84% |
| Slate Path Capital LP | 3,735,000 | $12,251,000 | 0.76% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $6,354,000 | 0.74% |
| Rubric Capital Management LP | 1,812,347 | $5,944,000 | 0.31% |
| Orbimed Advisors | 5,056,000 | $16,584,000 | 0.30% |
| Newtyn Management, LLC | 400,875 | $1,315,000 | 0.25% |
| Redmile Group, LLC | 1,920,960 | $6,301,000 | 0.24% |